Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Prepaid Assets (2019 - 2025)

Historic Prepaid Assets for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to $219.0 million.

  • Legend Biotech's Prepaid Assets rose 9414.1% to $219.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $219.0 million, marking a year-over-year increase of 9414.1%. This contributed to the annual value of $131.0 million for FY2024, which is 8923.19% up from last year.
  • According to the latest figures from Q3 2025, Legend Biotech's Prepaid Assets is $219.0 million, which was up 9414.1% from $219.1 million recorded in Q2 2025.
  • In the past 5 years, Legend Biotech's Prepaid Assets ranged from a high of $219.1 million in Q2 2025 and a low of $10425.0 during Q1 2021
  • For the 5-year period, Legend Biotech's Prepaid Assets averaged around $83.8 million, with its median value being $66.6 million (2023).
  • In the last 5 years, Legend Biotech's Prepaid Assets surged by 18313261.39% in 2022 and then soared by 1213.83% in 2023.
  • Quarter analysis of 5 years shows Legend Biotech's Prepaid Assets stood at $13.9 million in 2021, then soared by 345.82% to $61.8 million in 2022, then rose by 12.14% to $69.3 million in 2023, then soared by 89.23% to $131.0 million in 2024, then skyrocketed by 67.11% to $219.0 million in 2025.
  • Its last three reported values are $219.0 million in Q3 2025, $219.1 million for Q2 2025, and $182.0 million during Q1 2025.